BlackRock Institutional Trust’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3.19M Buy
651,615
+38,494
+6% +$231K ﹤0.01% 2885
2016
Q3
$4.75M Sell
613,121
-13,751
-2% -$92.6K ﹤0.01% 2714
2016
Q2
$3.51M Sell
626,872
-5,305
-0.8% -$33.9K ﹤0.01% 2831
2016
Q1
$3.4M Buy
632,177
+1,753
+0.3% +$10.2K ﹤0.01% 2826
2015
Q4
$5.49M Buy
630,424
+23,783
+4% +$201K ﹤0.01% 2672
2015
Q3
$5.09M Sell
606,641
-40,865
-6% -$651K ﹤0.01% 2708
2015
Q2
$11.4M Buy
647,506
+207,351
+47% +$2.66M ﹤0.01% 2317
2015
Q1
$5.09M Buy
440,155
+68,340
+18% +$791K ﹤0.01% 2749
2014
Q4
$3.74M Buy
371,815
+82,918
+29% +$420K ﹤0.01% 2842
2014
Q3
$1.31M Buy
288,897
+41,610
+17% +$223K ﹤0.01% 3233
2014
Q2
$1.67M Buy
247,287
+62,234
+34% +$469K ﹤0.01% 3269
2014
Q1
$2.37M Buy
185,053
+57,124
+45% +$632K ﹤0.01% 3093
2013
Q4
$1.04M Buy
+127,929
New +$1.13M ﹤0.01% 3385

Other funds holding SRNE